Cargando…

P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL

Detalles Bibliográficos
Autores principales: Wang, Yali, LI, Wenbin, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431005/
http://dx.doi.org/10.1097/01.HS9.0000971684.84535.92
_version_ 1785091095778033664
author Wang, Yali
LI, Wenbin
Chen, Feng
author_facet Wang, Yali
LI, Wenbin
Chen, Feng
author_sort Wang, Yali
collection PubMed
description
format Online
Article
Text
id pubmed-10431005
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310052023-08-17 P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL Wang, Yali LI, Wenbin Chen, Feng Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431005/ http://dx.doi.org/10.1097/01.HS9.0000971684.84535.92 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wang, Yali
LI, Wenbin
Chen, Feng
P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_full P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_fullStr P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_full_unstemmed P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_short P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_sort p1197: bruton’s tyrosine kinase inhibitor zanubrutinib in relapsed/refractory primary diffuse large b-cell lymphoma of central nervous system: a phase ii trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431005/
http://dx.doi.org/10.1097/01.HS9.0000971684.84535.92
work_keys_str_mv AT wangyali p1197brutonstyrosinekinaseinhibitorzanubrutinibinrelapsedrefractoryprimarydiffuselargebcelllymphomaofcentralnervoussystemaphaseiitrial
AT liwenbin p1197brutonstyrosinekinaseinhibitorzanubrutinibinrelapsedrefractoryprimarydiffuselargebcelllymphomaofcentralnervoussystemaphaseiitrial
AT chenfeng p1197brutonstyrosinekinaseinhibitorzanubrutinibinrelapsedrefractoryprimarydiffuselargebcelllymphomaofcentralnervoussystemaphaseiitrial